Expertise in

conditions

Giacomo P. Comi

Milan, IT

Clinical Trials:Currently Recruiting for 1 Trial

Expertise in

conditions

Milan, IT

Overview

Giacomo Comi practices practicing medicine in Milan, Italy.

Mr. Comi is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), Becker Muscular Dystrophy, Thrombectomy, and Gastrostomy.

He is actively involved in clinical research, co-authoring 354 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Milan, Italy

Other Locations

Rome, Italy

Pisa, Italy

Lecco, Italy

Ca' Granda, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Open Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies

Enrollment Status: Recruiting

Publish Date: January 21, 2026

Intervention Type: Drug

Study Phase: Phase 2/Phase 3

Long-Term Observational Study of Translarna Safety and Effectiveness in Usual Care

Enrollment Status: Completed

Publish Date: February 24, 2026

Journey: A Global, Multicenter, Longitudinal Study of the Natural History of Subjects With Limb Girdle Muscular Dystrophy (LGMD) Type 2E (LGMD2E/R4), Type 2D (LGMD2D/R3), Type 2C (LGMD2C/R5), and Type 2A (LGMD2A/R1)

Enrollment Status: Active_not_recruiting

Publish Date: November 06, 2025

A Randomised, Double Blind, Placebo Controlled Study to Evaluate the Micro-macroscopic Effects on Muscles, the Safety and Tolerability, and the Efficacy of Givinostat in Patients With Becker Muscular Dystrophy (BMD)

Enrollment Status: Completed

Publish Date: November 18, 2024

Intervention Type: Drug

Study Drug: Givinostat

Study Phase: Phase 2

Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy

Enrollment Status: Completed

Publish Date: February 02, 2023

Intervention Type: Drug

Study Drug: Givinostat

Study Phase: Phase 3

View 4 Less Clinical Trials

354 Total Publications

Clinical and pathological findings in two Italian siblings of Romani ancestry with charcot-marie-tooth type 4D and review of the current literature.

Journal: Journal of neuromuscular diseases

Published: May 06, 2026

View All 354 Publications

Frequently Asked Questions about Giacomo P. Comi

Is Giacomo P. Comi a top-rated expert for Primary Lateral Sclerosis?

MediFind is an objective health platform that identifies experts based on real-world data. Giacomo P. Comi is classified as an Elite expert for Primary Lateral Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Giacomo P. Comi participate in research or clinical trials?

Yes. Giacomo P. Comi has published 354 articles and abstracts on conditions like Primary Lateral Sclerosis. You can view a list of Giacomo P. Comi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Comi's expertise for a condition

ConditionClose